In this report, we evaluated the local and systemic metabolic effects resulting from a germline deficiency of metabolic regulator FGFR4 [30] on breast cancer development in the MMTV-TGFα mouse model [8,9]. The gene discussed is FGFR4; the disease is breast cancer.